发明名称 Antisense antiviral compounds and methods for treating a filovirus infection
摘要 The present invention provides antisense antiviral compounds, compositions, and methods of their use and production, mainly for inhibiting the replication of viruses of the Filoviridae family, including Ebola and Marburg viruses. The compounds, compositions, and methods also relate to the treatment of viral infections in mammals including primates by Ebola and Marburg viruses. The antisense antiviral compounds include phosphorodiamidate morpholino oligonucleotides (PMOplus) having a nuclease resistant backbone, about 15-40 nucleotide bases, at least two but typically no more than half piperazine-containing intersubunit linkages, and a targeting sequence that is targeted against the AUG start site region of Ebola virus VP35, Ebola virus VP24, Marburg virus VP24, or Marburg virus NP, including combinations and mixtures thereof.
申请公布号 US9382536(B2) 申请公布日期 2016.07.05
申请号 US201414196975 申请日期 2014.03.04
申请人 Sarepta Therapeutics, Inc. 发明人 Iversen Patrick L.;Weller Dwight D.
分类号 A61K48/00;C12N15/11;C07H21/02;C07H21/04;C12N15/113;A61K31/675;A61K31/713 主分类号 A61K48/00
代理机构 Seed IP Law Group PLLC 代理人 Seed IP Law Group PLLC
主权项 1. A morpholino antisense oligonucleotide of 23 bases comprising the base sequence of SEQ ID NO:79, wherein the morpholino antisense oligonucleotide is linked to a polyethylene glycol moiety.
地址 Corvallis OR US